Since 2010, two significant international regulations regarding medical device development have come into force, the amendment to the European Union (EU) Medical Device Directive (MDD) 2007/47/EC and the United States (US) Food and Drug Administration (FDA) final rule on Medical Device Data Systems (MDDS). Adherence to these regulations is mandatory to be able to market a medical device in the respective region. The ability to understand these regulations and apply them to a development project can be difficult. The MDDS final rule changes the safety classification of a number of devices from Class III-high risk to Class I-low risk. The aim of this regulation is to make the process of achieving regulatory approval for manufacturers easier. The MDD aims to provide guidance for the development of medical devices to be marketed for use within the EU. It also provides defined pathways which manufacturers can follow in order to achieve regulatory approval. However, changes made as part of an amendment to the directive have a direct impact on the development of medical devices. One of the most significant changes as part of this amendment is for software to be potentially considered as a medical device in its own right and potentially the only element in a medical device subject to regulatory conformance. These regulations have created confusion surrounding specific areas, such as the use of mobile device applications for healthcare purposes. This article describes the key points of these latest regulatory changes that medical device manufacturers need to be aware of.

References

References
1.
Borrás
,
C.
, 2006, “
Overexposure of Radiation Therapy in Panama
,” articles and special reports, pp.
173
187
.
2.
Leveson
,
N.
, 1995,
Safeware: System Safety and Computers
,
Addison Wesley
.
3.
European Council, 2007, Directive 2007/47/EC of the European Parliament and of the Council of 5 September 2007, European Council, ed.
4.
Federal Register, 2011, 73(31), 8637 (15 February 2011).
5.
McHugh
,
M.
,
McCaffery
,
F.
, and
Casey
,
V.
, 2011, “
Standalone Software as an Active Medical Device
,”
The 11th International SPICE Conference Process Improvement and Capability Determination
,
A.
Dorling
, ed.,
Springer
,
Dublin
, pp.
97
107
.
6.
European Commission, 1993, “
Council Directive 93/42/EEC of 14 June 1993 Concerning Medical Devices
.”
7.
European Commission, 1990, “
Council Directive 90/385/EEC of 20 June 1990 on the Approximation of the Laws of the Member States Relating to Active Implantable Medical Devices
.”
8.
European Commission, 1998, “
Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 Concerning the Placing of Biocidal Products on the Market
.”
9.
McCaffery
,
F.
,
Burton
,
J.
,
Casey
,
V.
, and
Dorling
,
A.
, 2010, “
Medical Device Industry: Software Process Improvement
,”
Encyclopedia of Software Engineering
,
P.
Laplanye
, ed.,
CRC Press Francis Taylor Group
,
London
, pp.
528
540
.
10.
McCaffery
,
F.
, and
Dorling
,
A.
, 2010, “
Medi SPICE: An Overview
,”
J. Softw. Maint. Evol.: Res. Pract.
,
22
(
4
), pp.
255
267
.
11.
McHugh
,
M.
,
McCaffery
,
F.
, and
Casey
,
V.
, 2011, “
How Amendments to the Medical Device Directive Affects the Development of Medical Device Software
,”
European Systems and Software Process Improvement and Innovation Conference
, EuroSPIRoskilde, Denmark.
12.
McHugh
,
M.
,
McCaffery
,
F.
, and
Casey
,
V.
, 2011, “
US FDA Releases Final Rule on Medical Device Data Systems—What Does This Mean for Device Manufacturers
,”
J. Med. Device Regul.
,
8
(
3
), pp.
35
40
.
13.
Buenafe
,
M.
, and
Bierman
,
M. E.
, 2011,
FDA Issues Final Rule for Medical Device Data Systems, Classifying Certain Heath IT Products
, Morgan Lewis.
14.
AAMI, 2006, “
ANSI/AAMI/IEC 62304, Medical Device Software—Software Life Cycle Processes
.”
15.
Commission Communication in the Framework of the Implementation of the Council Directive 93/42/EEC of 14 June 1993 Concerning Medical Devices (Publication of Titles and References of Harmonized Standards Under the Directive)
.”
16.
FDA, 2011, “
Draft Guidance for Industry and Food and Drug Administration—Mobile Device Applications
,” Center for Devices and Radiological Health.
17.
European Commission, 2012, “
Medical Devices Guidance Document—Qualification and Classification of Stand Alone Software MEDDEV 2.1/6
.”
You do not currently have access to this content.